UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050717
Receipt number R000057697
Scientific Title Multi-institutional prospective registry of initial chemotherapy combined with hyperthermia for locally advanced pancreatic cancer (JSTM-PAN01LA)
Date of disclosure of the study information 2023/03/30
Last modified on 2023/03/29 22:37:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multi-institutional prospective registry of initial chemotherapy combined with hyperthermia for locally advanced pancreatic cancer (JSTM-PAN01LA)

Acronym

Multi-institutional prospective registry of initial chemotherapy combined with hyperthermia for locally advanced pancreatic cancer (JSTM-PAN01LA)

Scientific Title

Multi-institutional prospective registry of initial chemotherapy combined with hyperthermia for locally advanced pancreatic cancer (JSTM-PAN01LA)

Scientific Title:Acronym

JSTM-PAN01LA

Region

Japan


Condition

Condition

Locally advanced pancreatic cancer

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to determine treatment efficacy, adverse events, and heating feasibility in hyperthermia combined with chemotherapy for locally advanced pancreatic cancer through a multi-institutional, prospective registry of patient data.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Progression-free survival

Key secondary outcomes

overall survival
Side effects


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Locally advanced pancreatic cancer, no distant metastases. Patients diagnosed with adenocarcinoma by tissue biopsy or cytology. However, patients within 2 months after the start of first chemotherapy are allowed.

Key exclusion criteria

Active multiple cancers (synchronous multiple cancers and heterochronic multiple cancers with a disease-free period of 5 years or less). However, epithelial cancer, lesions equivalent to intramucosal cancer, and skin cancer that are considered curable by local treatment are not included as active overlapping cancers.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Takayuki
Middle name
Last name Ohguri

Organization

University Hospital of Occupational and Environmental Hralth

Division name

Department of Therapeutic Radiology

Zip code

807-8555

Address

1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-shi, Fukuoka

TEL

093-603-1611

Email

ogurieye@med.uoeh-u.ac.jp


Public contact

Name of contact person

1st name Takayuki
Middle name
Last name Ohguri

Organization

University Hospital of Occupational and Environmental Hralth

Division name

Department of Therapeutic Radiology

Zip code

807-8555

Address

1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-shi, Fukuoka

TEL

093-603-1611

Homepage URL


Email

ogurieye@med.uoeh-u.ac.jp


Sponsor or person

Institute

Department of Therapeutic Radiology
University Hospital of Occupational and Environmental Hralth

Institute

Department

Personal name



Funding Source

Organization

Department of Therapeutic Radiology
University Hospital of Occupational and Environmental Hralth

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Occupational and Environmental Hralth

Address

1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-shi, Fukuoka

Tel

093-603-1611

Email

ogurieye@med.uoeh-u.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

UOEHCRB22-036

Org. issuing International ID_1

University of Occupational and Environmental Hralth

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 11 Month 11 Day

Date of IRB

2022 Year 11 Month 11 Day

Anticipated trial start date

2022 Year 11 Month 15 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The purpose of this study is to determine treatment efficacy, adverse events, and heating feasibility in hyperthermia combined with chemotherapy for locally advanced pancreatic cancer through a multi-institutional, prospective registry of patient data.


Management information

Registered date

2023 Year 03 Month 29 Day

Last modified on

2023 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057697